LifeMD to Participate in Three Investor Conferences During May

LifeMD, Inc. (Nasdaq: LFMD), a prominent provider of virtual primary care services, has announced its participation in three key investor conferences throughout May 2025. These events offer an opportunity for the company’s management to engage with current and potential investors while showcasing LifeMD’s innovative healthcare model.

The first event is the H.C. Wainwright 3rd Annual BioConnect Investor Conference, scheduled for May 20 in New York City. During this conference, LifeMD’s management will conduct one-on-one meetings with investors, providing insights into the company's strategies and growth potential.

Following this, LifeMD will participate in the B. Riley Securities 25th Annual Institutional Investor Conference, taking place from May 21 to 22 at the Ritz-Carlton in Marina Del Rey. Here, the management team will deliver a corporate overview and engage in one-on-one meetings, emphasizing the company's mission and its approaches to delivering accessible healthcare.

The final conference is the Craig-Hallum 22nd Annual Institutional Investor Conference on May 28 at The Depot Renaissance Minneapolis Hotel. This event will also feature one-on-one and small group meetings, allowing for more personalized discussions about LifeMD’s services and overall business strategy.

LifeMD distinguishes itself as a leader in virtual primary care by leveraging a proprietary digital care platform and a 50-state affiliated medical group. With the ability to provide services for over 200 conditions—including primary care, men’s and women’s health, weight management, and hormone therapy—the company is committed to increasing access to high-quality, affordable healthcare through innovative telemedicine solutions. For more details, interested parties can visit LifeMD.com.

For media inquiries, contact Jessica Friedeman, Chief Marketing Officer, while investor-related questions can be directed to Marc Benathen, Chief Financial Officer.

LifeMD, Inc. (Nasdaq: LFMD) is making significant strides in the virtual primary care sector, and its participation in three key investor conferences this May is indicative of its proactive approach to enhancing visibility and attracting institutional interest. The upcoming conferences—the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, the B. Riley Securities 25th Annual Institutional Investor Conference on May 21-22, and the Craig-Hallum 22nd Annual Institutional Investor Conference on May 28—provide a valuable platform for management to engage directly with investors through presentations and one-on-one meetings.

The company's innovative telemedicine solutions address a growing market need for accessible healthcare services, particularly in the wake of the ongoing shift towards digital health solutions. With a comprehensive service offering that spans over 200 conditions and a robust infrastructure—including a proprietary digital care platform and a nationwide medical group—LifeMD is well-equipped to capitalize on this trend.

For potential investors, this series of conferences presents an opportunity to gain deeper insights into LifeMD's operational strategy, competitive positioning, and growth trajectory. The management's ability to convey its vision and milestones during these meetings could serve as a pivotal moment for investors assessing the stock's long-term potential.

As LifeMD seeks to expand its market share and enhance its service portfolio, the engagement with key industry investors will be crucial. Investors should consider the implications of LifeMD's efforts in enhancing patient care access, as well as the broader market dynamics affecting telehealth. Given the promising outlook for virtual healthcare solutions, LifeMD may represent an attractive investment opportunity, particularly for those interested in the intersection of technology and healthcare.

In summary, monitoring LifeMD's developments and outcomes from these conferences could yield valuable insights for informed investment decisions.